Mitsuru Sakakibara

发表

TIE2‐expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis

H. Nagano, N. Hayashi, A. Kasahara, 2013, Hepatology.

Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll‐like receptors and retinoic acid inducible gene‐I

N. Hayashi, A. Kasahara, N. Hiramatsu, 2008, Journal of medical virology.

Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis

N. Hayashi, A. Kasahara, N. Hiramatsu, 2009, Journal of viral hepatitis.

Impaired ability of interferon‐alpha‐primed dendritic cells to stimulate Th1‐type CD4 T‐cell response in chronic hepatitis C virus infection

N. Hayashi, A. Kasahara, N. Hiramatsu, 2007, Journal of viral hepatitis.

Analysis of monitoring adverse events and problems in the treatment with sorafenib for hepatocellular carcinoma

K. Imanaka, K. Ohkawa, M. Sakakibara, 2013 .

TIE2‐expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis

H. Nagano, N. Hayashi, A. Kasahara, 2013, Hepatology.

Development of a thrombus in the superior mesenteric artery associated with sequential therapy with tyrosine kinase inhibitors for hepatocellular carcinoma

K. Ohkawa, K. Ikezawa, N. Fukutake, 2019, Clinical Journal of Gastroenterology.

Involvement of the p38 mitogen‐activated protein kinase cascade in hepatocellular carcinoma

N. Hayashi, J. Wands, Y. Sasaki, 2003, Cancer.

Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon‐α and ribavirin therapy for chronic hepatitis C patients

N. Hayashi, A. Kasahara, N. Hiramatsu, 2007, Journal of medical virology.

Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection.

N. Hayashi, A. Kasahara, N. Hiramatsu, 2004, The Journal of infectious diseases.

Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide

N. Hayashi, A. Kasahara, N. Hiramatsu, 2011, Cancer Immunology, Immunotherapy.

Quick Generation of Fully Mature Dendritic Cells From Monocytes With OK432, Low-Dose Prostanoid, and Interferon-α as Potent Immune Enhancers

N. Hayashi, A. Kasahara, N. Hiramatsu, 2006, Journal of immunotherapy.

Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection

Y. Imai, N. Hayashi, A. Kasahara, 2013, Journal of Gastroenterology.

Prognostic Factors for Patients With a Large Number of Hepatocellular Carcinoma Nodules

T. Tabuchi, K. Ohkawa, H. Hikita, 2020, Journal of clinical medicine research.

Prospective Comparison of Gd-EOB-DTPA-Enhanced MRI with Dynamic CT for Detecting Recurrence of HCC after Radiofrequency Ablation

T. Murakami, Y. Imai, Tonsok Kim, 2017, Liver Cancer.

Clinical Trial of the Intratumoral Administration of Labeled DC Combined With Systemic Chemotherapy for Esophageal Cancer

E. Shimosegawa, J. Hatazawa, Y. Doki, 2012, Journal of immunotherapy.

Enhanced ability of peripheral invariant natural killer T cells to produce IL-13 in chronic hepatitis C virus infection.

N. Hayashi, A. Kasahara, N. Hiramatsu, 2006, Journal of hepatology.

Usefulness of Whole Body MRI detecting extrahepatic metastasis of HCC: Three case reports

K. Ohkawa, K. Ikezawa, N. Fukutake, 2019, Kanzo.

Impaired Function of Dendritic Cells Circulating in Patients Infected with Hepatitis C Virus Who Have Persistently Normal Alanine Aminotransferase Levels

N. Hayashi, A. Kasahara, N. Hiramatsu, 2005, Intervirology.

Pseudotype hepatitis C virus enters immature myeloid dendritic cells through the interaction with lectin.

N. Hayashi, T. Takehara, Y. Matsuura, 2004, Virology.

Two-step progression of varenicline-induced autoimmune hepatitis

K. Ohkawa, M. Sakakibara, K. Katayama, 2018, Clinical Journal of Gastroenterology.

Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma

N. Hiramatsu, K. Imanaka, K. Ohkawa, 2023, PloS one.

Effect of zinc supplementation in patients with type C liver cirrhosis

K. Imanaka, K. Ohkawa, M. Sakakibara, 2011 .

Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study

N. Hiramatsu, K. Imanaka, K. Ohkawa, 2024, PloS one.